Entrada Therapeutics Inc (TRDA)
17.74
+0.14
(+0.82%)
USD |
NASDAQ |
Nov 04, 16:00
17.76
+0.01
(+0.06%)
After-Hours: 20:00
Entrada Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Fulcrum Therapeutics Inc | -- |
| Sarepta Therapeutics Inc | 87.73% |
| Catalyst Pharmaceuticals Inc | 87.45% |
| Vertex Pharmaceuticals Inc | 85.94% |
| Regenxbio Inc | 52.55% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 37.43% |
| Return on Assets | 20.55% |
| Return on Invested Capital | 37.43% |
| Profit Margin (Quarterly) | 58.11% |
| Operating Margin (Quarterly) | 56.42% |
| Return on Net Operating Assets | 88.36% |